USD 0.01
(-2.2%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 419.29 Thousand USD | 2070.73% |
2022 | 19.31 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | -100.0% |
2018 | 1543.00 USD | 0.0% |
2016 | 1.54 Million USD | -60.48% |
2015 | 3.9 Million USD | -46.95% |
2014 | 7.36 Million USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q4 | 238.07 Thousand USD | 103.09% |
2023 FY | 419.29 Thousand USD | 2070.73% |
2023 Q3 | 117.22 Thousand USD | 101.19% |
2023 Q1 | 5730.00 USD | 299.03% |
2023 Q2 | 58.26 Thousand USD | 916.86% |
2022 FY | 19.31 Thousand USD | 0.0% |
2022 Q3 | 17.06 Thousand USD | 1991.18% |
2022 Q4 | 1436.00 USD | -91.58% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | 816.00 USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2019 FY | - USD | -100.0% |
2018 FY | 1543.00 USD | 0.0% |
2016 FY | 1.54 Million USD | -60.48% |
2015 FY | 3.9 Million USD | -46.95% |
2014 FY | 7.36 Million USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | 86.862% |
Ansell Limited | 1.61 Billion USD | 99.974% |
Ansell Limited | 1.61 Billion USD | 99.974% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 184.64 Million USD | 99.773% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 135.05 Thousand USD | -210.465% |
ConvaTec Group Plc | 2.19 Billion USD | 99.981% |
ConvaTec Group Plc | 2.14 Billion USD | 99.98% |
Encision Inc. | 6.58 Million USD | 93.633% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 1.82 Million USD | 77.024% |
LifePoint, Inc. | -18.5 Thousand USD | 2366.481% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 93.846% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | 45.687% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 986.22 Thousand USD | 57.484% |
Reflect Scientific, Inc. | 1.08 Million USD | 61.182% |
SmileDirectClub, Inc. | 470.74 Million USD | 99.911% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 99.978% |
SheerVision, Inc. | 3.49 Million USD | 88.018% |
United Health Products, Inc. | - USD | -Infinity% |
Vasamed, Inc. | 1.38 Million USD | 69.754% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | 43.725% |
Yubo International Biotech Limited | 104.28 Thousand USD | -302.078% |